Workflow
新威凌(871634) - 2024 Q1 - 季度财报

Financial Performance - Operating revenue for Q1 2024 reached ¥150,331,676.84, a growth of 31.38% year-on-year[11] - Net profit attributable to shareholders rose by 74.18% to ¥5,294,531.78 compared to the same period last year[11] - Total operating revenue for Q1 2024 reached ¥150,331,676.84, a 31.3% increase from ¥114,424,720.16 in Q1 2023[33] - Net profit for Q1 2024 was ¥5,294,531.78, representing a 74.2% increase compared to ¥3,039,686.80 in Q1 2023[34] - The total profit for Q1 2024 was ¥5,681,290.01, up 103.5% from ¥2,801,130.57 in Q1 2023[33] - Basic and diluted earnings per share for Q1 2024 were both ¥0.08, compared to ¥0.05 in Q1 2023[34] Assets and Liabilities - Total assets increased by 11.40% to ¥320,131,756.35 compared to the end of last year[11] - Current assets rose to ¥230.97 billion, up from ¥201.17 billion, marking an increase of about 14.8%[30] - Total liabilities increased to ¥70.08 billion from ¥42.76 billion, representing a growth of around 63.8%[29] - The company's equity attributable to shareholders reached ¥250.06 billion, up from ¥244.62 billion, showing an increase of about 2.0%[30] - Non-current assets totaled ¥89.16 billion, slightly up from ¥86.20 billion, reflecting a growth of about 3.4%[30] Cash Flow - The company’s cash flow from financing activities surged by 1,387.13% to ¥37,011,843.38, driven by increased short-term borrowings[14] - Operating cash inflow for Q1 2024 was CNY 124,894,297.74, an increase of 27% compared to CNY 98,391,137.02 in Q1 2023[38] - Net cash outflow from operating activities was CNY -27,038,778.05, slightly improved from CNY -27,943,389.96 in the same period last year[38] - Financing cash inflow for Q1 2024 was CNY 50,300,000.00, significantly higher than CNY 10,000,000.00 in Q1 2023[39] - Net cash inflow from financing activities was CNY 37,011,843.38, compared to CNY 2,488,805.58 in the same period last year[39] Shareholder Information - The total number of ordinary shares is 62,322,000, with 4,986 shareholders[19] - The largest shareholder, Chen Zhiqiang, holds 14,568,500 shares, representing 23.38% of total shares[20] - The second-largest shareholder, Liao Xinglie, holds 14,297,870 shares, representing 22.94% of total shares[20] - The company has a total of 46,828,080 restricted shares, accounting for 75.14% of total shares[18] - The company has a total of 15,493,920 unrestricted shares held by controlling shareholders, representing 24.86% of total shares[18] Research and Development - Research and development expenses increased by 58.48% to ¥5,101,098.96, reflecting a commitment to enhance product competitiveness[12] - Research and development expenses increased to ¥5,101,098.96 in Q1 2024, up 58.5% from ¥3,218,795.00 in Q1 2023[33] Other Financial Metrics - The gross profit margin improved, contributing to a 99.79% increase in operating profit to ¥5,696,290.01[12] - Other income increased by 154.36% to ¥1,408,111.28, primarily due to higher government subsidies[12] - Credit impairment losses for Q1 2024 were ¥1,097,943.30, a significant increase from a reversal of ¥828,597.16 in Q1 2023[33] Inventory and Receivables - Accounts receivable rose significantly by 92.85% to ¥82,958,861.38 due to higher sales revenue in March 2024[12] - Inventory decreased to ¥38.92 billion from ¥51.62 billion, a decline of about 24.6%[28] - Accounts receivable rose to ¥82.96 billion, compared to ¥43.02 billion, reflecting an increase of approximately 93.5%[28] Legal and Compliance - The company has no ongoing litigation or arbitration matters[24] - There are no significant related party transactions reported during the period[24] - The company has not reported any major asset freezes or pledges[24]